NCT02176525View on ClinicalTrials.gov

Multiple Oral Doses of BI 207127 NA in Treatment naïve and Treatment-experienced Hepatitis C Virus (HCV)-Infected Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2009

Conditions
Hepatitis C, Chronic
Interventions
DRUG

BI 207127 NA

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY